온라인강의
강사명Hwaseung Yoo
강의시간17분
강의개설일2025-12-09
강의소개
Cancer is one of the leading causes of death worldwide, and Korea is no exception. Humanity has been
fighting cancer for many years, and as a result, we now have effective treatments such as chemotherapy, radiation, and
surgery. However, there are other issues that we are only now beginning to address, such as cancer patients’ quality
of life. Moreover, numerous studies show that addressing these issues holistically is critical for overall cancer treatment
and survival rates. This paper describes how Korea is attempting to reduce cancer incidence and recurrence rates while
also managing the quality of life of cancer patients. Integrative Oncology is the field that addresses these broad issues,
and understanding the current state of integrative oncology in Korea is critical. The goal of this paper is to provide an
overview of the current state of integrative oncology in Korea as well as to look ahead to future developments.
강사소개
Dr. Hwaseung Yoo received his MD (DKM)., M.Sc. and Ph.D from Daejeon University,
Korea. He has completed oncology residency at the East West Cancer Center (EWCC) of Daejeon
University Korean Medicine Hospital and research fellowship at the Cancer Clinic of Guang-An-Men Hospital, Beijing,
China. Dr. Yoo is a tenured professor of College of Korean Medicine at Daejeon University and former head of Seoul
Korean Medical Hospital of Daejeon University as well as director of East West Cancer Center & Integrative Immunotherapy
Center where he specializes in integrative cancer therapies. He is the developer of Wheel Balance Cancer Therapy (WBCT),
EWCC’s standard cancer regimen which incorporates interventions of Traditional Korean Medicine (TKM) to conventional
cancer treatment. His case series submissions have been selected for US National Cancer Institute (NCI)’s Best Case Series
Program, the results were published on Integrative Cancer Therapies in 2009 and 2010. An overview of WBCT program
and the retrospective survival outcomes of advanced non-small lung cancer patients were introduced on the same journal
in 2010 and 2016. Primary focuses of his researches are investigating the biochemical mechanisms and clinical effects
of herbal extracts and incorporating different treatment methods using the herbs, acupuncture, pharmacopuncture, etc.
His notable publications are Integrative Oncology (E-public, 2009), Pharmacopuncturology (Elsevier, 2011), Integrative
Oncology in Korean Traditional Medicine (Gunja, 2013), Integrative Oncology 2nd edition (E-public, 2017), K Integrative
Oncology (Korean Economic Pub, 2018) and over 500 research papers including 150 international journals. He has
served as a visiting associate professor at Integrative Medical Program in the University of Texas MD Anderson Cancer
Center for one year in 2012. Now he is serving as PIs for the development of an anti lung cancer herbal medication,
acupuncture for breast cancer patient, and platform establishment for Korean traditional oncology from Ministry of Health &
Welfare. World Health Organization (WHO) Regional Office for the Western Pacific nominated him as a Traditional Korean
Medicine oncology specialist in 2005. He was also featured on the 10th anniversary edition of 2008-2009 Marquis
Who's Who in Science and Engineering. He has been an executive board member of the Society for Integrative Oncology
(SIO) now. He also has served on the editorial boards members of Integrative Cancer Therapies (ICT), Journal of Korean
Academy of Traditional Oncology (JKATO), etc. Now he serves a Co-President of Korean Society of Integrative Oncology
(KSIO) and President of Korean Association of Traditional Oncology (KATO).